转录因子在癌症中的ubiquitination:揭示治疗潜力
Dongha Kim1, Hye Jin Nam2,3, Sung Hee Baek4
1Department of Anatomy, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Molecular oncology
|April 14, 2025
概括
转录因子的改变无处不在驱动癌症的生长. 通过调节这些因素,准无素-蛋白酶体系统提供了新的癌症疗法.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生化学
背景情况:
- 转录因子调节基因表达,在癌症中至关重要.
- 翻译后的修改,如ubiquitination,控制转录因子的活动.
- 转录因子的不受调节的泛化有助于瘤生长和存活.
研究的目的:
- 审查转录因子无化对癌症进展的关键影响.
- 概述针对癌症中的无素-蛋白酶系统的新型治疗策略.
主要方法:
- 文献综述侧重于无处不在,转录因子和癌症.
- 分析了泛素E3链酶和二聚胺酶 (DUBs) 的作用.
主要成果:
- 异常的无处不在可以导致瘤抑制剂 (例如,p53) 的降解或瘤原因子的稳定.
- 无素蛋白酶体系统 (UPS) 是癌症发展的关键调节器.
- 针对UPS组件提供了潜在的治疗途径.
结论:
- 转录因子的改变无处不在是癌症的重要驱动因素.
- 针对特定E3结合酶和DUBs的治疗策略在癌症治疗中显示出前景.
更多相关视频
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
2.7K
08:12Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
Published on: January 8, 2018
11.2K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Transcription Factors
75.4K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.4K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Induced Pluripotent Stem Cells
3.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.8K
